Accès ouvert
2024
article
OpenAlex
Sari Mishina, Yuichiro Ito, Takumi Lee, Toshiaki Murofushi et autres
Background: Several treatment options are available for anemia associated with chronic kidney disease (CKD); however, there remains a lack of awareness of physician and patient preferences regarding these treatments. We aimed to explore physicians' and patients' perceptions and preferences regarding the management …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Akio Tanaka, Akira Yuasa, Kazumasa Kamei, Mitsuhiro Nagano et autres
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a significant clinical, economic, and human burden. The JAK1 Atopic Dermatitis Efficacy and Safety (JADE) program's Phase 3 trials demonstrated that as a treatment for moderate-to-severe AD in adults with previous exposure …
jp, us
(code pays fourni par la source)
Accès ouvert
2022
review
OpenAlex
Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Toshiaki Murofushi et autres
INTRODUCTION: In light of the lack of an agreed international standard for how to conduct cost-effectiveness analyses (CEAs), including cost-utility analyses (CUAs) from a societal perspective, there is uncertainty regarding to what extent the inclusion of productivity losses/gains in economic evaluations can …
jp
(code pays fourni par la source)
Accès ouvert
2022
review
OpenAlex
Atsuyuki Igarashi, Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei et autres
INTRODUCTION: Psoriasis (PSO), atopic dermatitis (AD), and chronic urticaria (CU) are common manifestations of immunological skin and subcutaneous conditions and have been shown to have a substantial impact on the quality of life of patients. The cost of treating those conditions can …
jp
(code pays fourni par la source)